- Home
- TKLF vs NVNO Comparison
TKLF vs NVNO Comparison
Compare TKLF & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKLF
- NVNO
- Stock Information
- Founded
- TKLF 2006
- NVNO 1987
- Country
- TKLF Japan
- NVNO United States
- Employees
- TKLF N/A
- NVNO N/A
- Industry
- TKLF Other Specialty Stores
- NVNO Medical/Dental Instruments
- Sector
- TKLF Consumer Discretionary
- NVNO Health Care
- Exchange
- TKLF Nasdaq
- NVNO Nasdaq
- Market Cap
- TKLF 15.6M
- NVNO 16.7M
- IPO Year
- TKLF 2022
- NVNO N/A
- Fundamental
- Price
- TKLF $3.30
- NVNO $0.70
- Analyst Decision
- TKLF
- NVNO
- Analyst Count
- TKLF 0
- NVNO 0
- Target Price
- TKLF N/A
- NVNO N/A
- AVG Volume (30 Days)
- TKLF 171.8K
- NVNO 338.1K
- Earning Date
- TKLF 12-17-2025
- NVNO 10-31-2025
- Dividend Yield
- TKLF N/A
- NVNO N/A
- EPS Growth
- TKLF N/A
- NVNO N/A
- EPS
- TKLF 1.57
- NVNO N/A
- Revenue
- TKLF $210,119,238.00
- NVNO N/A
- Revenue This Year
- TKLF N/A
- NVNO N/A
- Revenue Next Year
- TKLF N/A
- NVNO N/A
- P/E Ratio
- TKLF $2.10
- NVNO N/A
- Revenue Growth
- TKLF 7.38
- NVNO N/A
- 52 Week Low
- TKLF $2.20
- NVNO $0.62
- 52 Week High
- TKLF $5.10
- NVNO $5.62
- Technical
- Relative Strength Index (RSI)
- TKLF 43.02
- NVNO 31.70
- Support Level
- TKLF $3.04
- NVNO $0.68
- Resistance Level
- TKLF $3.48
- NVNO $0.74
- Average True Range (ATR)
- TKLF 0.26
- NVNO 0.06
- MACD
- TKLF -0.00
- NVNO 0.03
- Stochastic Oscillator
- TKLF 43.77
- NVNO 42.51
About TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.